CCAAT/enhancer-binding protein (C/EBP␣) can appoint mouse bone marrow (MBM) cells to the osteoclast (OC) lineage for osteoclastogenesis. However, whether C/EBP␣ is also involved in OC differentiation and activity is unknown. Here we demonstrated that C/EBP␣ overexpression in MBM cells can promote OC differentiation and strongly induce the expression of the OC genes encoding the nuclear factor of activated T-cells, c1 (NFATc1), cathepsin K (Cstk), and tartrate-resistant acid phosphatase 5 (TRAP) with receptor activator of NF-B ligandevoked OC lineage priming. Furthermore, while investigating the specific stage of OC differentiation that is regulated by C/EBP␣, our gene overexpression studies revealed that, although C/EBP␣ plays a stronger role in the early stage of OC differentiation, it is also involved in the later stage. Accordingly, C/EBP␣ knockdown drastically inhibits osteoclastogenesis and markedly abrogates the expression of NFATc1, Cstk, and TRAP during OC differentiation. Consistently, C/EBP␣ silencing revealed that, although lack of C/EBP␣ affects all stages of OC differentiation, it has more impact on the early stage. Importantly, we showed that ectopic expression of rat C/EBP␣ restores osteoclastogenesis in C/EBP␣-depleted MBM cells. Furthermore, our subsequent functional assays showed that C/EBP␣ exhibits a dispensable role on actin ring formation by mature OCs but is critically involved in bone resorption by stimulating extracellular acidification and regulating cell survival. We revealed that C/EBP␣ is important for receptor activator of NF-B ligand-induced Akt activation, which is crucial for OC survival. Collectively, these results indicate that C/EBP␣ functions throughout osteoclastogenesis as well as in OC function. This study provides additional understanding of the roles of C/EBP␣ in OC biology.
C/EBP␣3 is a transcription factor of the C/EBP family of transcription factors, and members of this family share a conserved leucine zipper dimerization domain (1). C/EBP␣ is critical for hematopoiesis and granulopoiesis in particular through induction of myeloid lineage-specific genes and regulation of the cell cycle for cell differentiation (2, 3). Thereby, C/EBP␣ can couple cell lineage commitment to terminal cell differentiation (4, 5). This is underscored by studies demonstrating that global deletion of the C/EBP␣ gene in mice (C/EBP␣ Ϫ/Ϫ mice) causes early death and a lack of mature granulocytes aside from other issues related to defective homeostasis (6) (7). Consistently, conditional deletion of the C/EBP␣ gene in adult mice impedes the differentiation of granulocytes, leading to an increase in myeloblasts (8). As a result, mutations that affect C/EBP␣ expression and/or function have been shown to be strongly associated with certain types of acute myeloid leukemia in humans (4, 9, 10). Notably, we have recently revealed a novel role for C/EBP␣ in osteoclastogenesis by mediating the commitment of OC precursors from the hematopoietic cell lineage into the OC lineage (11).OCs are polykaryon bone...